Samuel G. Rayner

1.4k total citations
40 papers, 839 citations indexed

About

Samuel G. Rayner is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Samuel G. Rayner has authored 40 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Samuel G. Rayner's work include Pulmonary Hypertension Research and Treatments (15 papers), Angiogenesis and VEGF in Cancer (5 papers) and 3D Printing in Biomedical Research (5 papers). Samuel G. Rayner is often cited by papers focused on Pulmonary Hypertension Research and Treatments (15 papers), Angiogenesis and VEGF in Cancer (5 papers) and 3D Printing in Biomedical Research (5 papers). Samuel G. Rayner collaborates with scholars based in United States, United Kingdom and India. Samuel G. Rayner's co-authors include Ying Zheng, Nicholas M. Mark, J. Randall Curtis, Christian Mandrycky, Nobuaki Kikyo, Liudmila Romanova, Nobuko Katoku-Kikyo, Caitlin Howard, Liying Zhang and Peter J. Leary and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of the American College of Cardiology.

In The Last Decade

Samuel G. Rayner

38 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel G. Rayner United States 15 224 182 160 143 83 40 839
Kai Tisljar Switzerland 18 270 1.2× 127 0.7× 203 1.3× 60 0.4× 90 1.1× 46 1.2k
Thanh N. Huynh United States 11 314 1.4× 32 0.2× 208 1.3× 121 0.8× 66 0.8× 16 831
Jeannette Capella United States 9 159 0.7× 49 0.3× 147 0.9× 51 0.4× 56 0.7× 14 1.1k
Marijana Lijovic Australia 15 52 0.2× 88 0.5× 87 0.5× 60 0.4× 89 1.1× 20 725
P. Connor Johnson United States 17 72 0.3× 57 0.3× 248 1.6× 67 0.5× 100 1.2× 73 997
Clíona McDowell United Kingdom 15 140 0.6× 57 0.3× 30 0.2× 503 3.5× 88 1.1× 45 1.1k
Ahmed Elgebaly Egypt 16 89 0.4× 33 0.2× 97 0.6× 94 0.7× 61 0.7× 49 871
Jennifer G. Wilson United States 14 214 1.0× 56 0.3× 161 1.0× 606 4.2× 11 0.1× 35 1.5k
Kojiro Onizawa Japan 20 327 1.5× 73 0.4× 40 0.3× 310 2.2× 33 0.4× 73 1.3k
Emiko Nakataki Japan 16 135 0.6× 46 0.3× 18 0.1× 373 2.6× 35 0.4× 37 751

Countries citing papers authored by Samuel G. Rayner

Since Specialization
Citations

This map shows the geographic impact of Samuel G. Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel G. Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel G. Rayner more than expected).

Fields of papers citing papers by Samuel G. Rayner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel G. Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel G. Rayner. The network helps show where Samuel G. Rayner may publish in the future.

Co-authorship network of co-authors of Samuel G. Rayner

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel G. Rayner. A scholar is included among the top collaborators of Samuel G. Rayner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel G. Rayner. Samuel G. Rayner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leary, Peter J., Samuel G. Rayner, Kelley R. Branch, et al.. (2025). Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension. CHEST Journal. 168(1). 189–199.
2.
Leary, Peter J., Sumeet Panjabi, John M. Hartney, et al.. (2025). Location of Care Delivery for Pulmonary Arterial Hypertension in the United States. American Journal of Respiratory and Critical Care Medicine. 211(4). 619–627. 1 indexed citations
3.
Xia, Lu, Olivier Boucherat, Karthik Suresh, et al.. (2024). Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension. Circulation Heart Failure. 17(11). e012067–e012067. 2 indexed citations
4.
Rayner, Samuel G., Ryan J. Tedford, Peter J. Leary, Susanna Mak, & Brian A. Houston. (2024). “This Patient Needs a Doctor, Not a Guideline!” The Zone of Uncertainty in Pulmonary Arterial Wedge Pressure Measurement. American Journal of Respiratory and Critical Care Medicine. 210(6). 712–714. 14 indexed citations
5.
Rayner, Samuel G., Chi F. Hung, W. Conrad Liles, & William A. Altemeier. (2023). Lung pericytes as mediators of inflammation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 325(1). L1–L8. 14 indexed citations
6.
Hough, Catherine L., et al.. (2023). Premorbid weight in pulmonary arterial hypertension. Pulmonary Circulation. 13(4). e12308–e12308. 1 indexed citations
7.
Chen, Delphine L., Michael S. Mulligan, Karen Ordovás, et al.. (2023). Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience. Respiratory Medicine. 211. 107215–107215. 2 indexed citations
8.
Xia, Lu, David Ralph, Samuel G. Rayner, et al.. (2023). Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes. Circulation Research. 132(3). 254–266. 28 indexed citations
9.
Michailidou, Despina, Delphine L. Chen, Bridget F. Collins, et al.. (2023). Large Vessel Vasculitis in a Young Woman with EIF2AK4-associated Pulmonary Capillary Hemangiomatosis/Pulmonary Veno-Occlusive Disease. American Journal of Respiratory and Critical Care Medicine. 208(5). e29–e31. 2 indexed citations
10.
Rayner, Samuel G., et al.. (2022). Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension. BMJ Open Respiratory Research. 9(1). e001348–e001348. 5 indexed citations
11.
Berardi, Cecilia, David A. Bluemke, Brian A. Houston, et al.. (2022). Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study. The Journal of Heart and Lung Transplantation. 41(5). 619–625. 4 indexed citations
12.
Ralph, David, Ying Zheng, William A. Altemeier, et al.. (2022). Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 42(2). 173–182. 17 indexed citations
13.
Houston, Brian A., David A. Bluemke, Steven M. Kawut, et al.. (2021). Associations of Angiopoietins With Heart Failure Incidence and Severity. Journal of Cardiac Failure. 27(7). 786–795. 19 indexed citations
14.
Mandrycky, Christian, Caitlin Howard, Samuel G. Rayner, Yu Jung Shin, & Ying Zheng. (2021). Organ-on-a-chip systems for vascular biology. Journal of Molecular and Cellular Cardiology. 159. 1–13. 62 indexed citations
15.
Burger, Charles D., Daniel Grinnan, David Ralph, et al.. (2020). A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care. Annals of the American Thoracic Society. 17(12). 1576–1582. 39 indexed citations
16.
Ralph, David, et al.. (2020). PLASMA METABOLITE PROFILES ARE ASSOCIATED WITH RIGHT VENTRICULAR DYSFUNCTION AND PROGNOSIS IN PULMONARY ARTERIAL HYPERTENSION. Journal of the American College of Cardiology. 75(11). 2082–2082. 1 indexed citations
17.
Houston, Brian A., David A. Bluemke, Todd M. Kolb, et al.. (2020). Angiopoietin Associations Across the Cardiovascular Disease Spectrum: The Mesa Angiogenesis Study. A4239–A4239. 1 indexed citations
18.
Leary, Peter J., Nancy S. Jenny, David A. Bluemke, et al.. (2019). Endothelin-1, cardiac morphology, and heart failure: the MESA angiogenesis study. The Journal of Heart and Lung Transplantation. 39(1). 45–52. 14 indexed citations
19.
Rayner, Samuel G., et al.. (2016). The Predictive Value of the Modified Glasgow Prognostic Score (Mgps) in Determining Outcome Following Elective Colorectal Cancer Surgery. 1(1). 1 indexed citations
20.
Lindström, Björn, et al.. (1969). [Attempts at intensive care of cases of severe mental retardation].. PubMed. 66(12). 1223–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Tisljar Breakdown of academic impact, for papers by Thanh N. Huynh Breakdown of academic impact, for papers by Jeannette Capella Breakdown of academic impact, for papers by Marijana Lijovic Breakdown of academic impact, for papers by P. Connor Johnson Breakdown of academic impact, for papers by Clíona McDowell Breakdown of academic impact, for papers by Ahmed Elgebaly Breakdown of academic impact, for papers by Jennifer G. Wilson Breakdown of academic impact, for papers by Kojiro Onizawa Breakdown of academic impact, for papers by Emiko Nakataki
Rankless by CCL
2026